Ashland Global (ASH)

NYSE Materials Diversified Chemicals S&P MidCap 400
$76.62
+0.34 (+0.45%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Not scheduled yet
No report date announced in the next three weeks.
Consensus EPS estimate
—
Shown once a date is announced.
Last report (Nov 03)
$1.12 vs $1.30 est.
Surprise -13.8%

Earnings surprise history

reported EPS vs consensus
ReportedQuarterEPS estimateReported EPSSurprise
Nov 03, 2026Sep/2026$1.30$1.12-13.8%

Our record of ASH's reports since we began tracking; it grows each quarter.

Latest results, in brief

All ASH 8-K briefs →
Nov 3, 5:27 PM ET

Ashland Q4 sales rise 4% to $498 million, but it posts a $16 million net loss

Mixed earnings 2.027.01

Ashland reported preliminary fourth-quarter fiscal 2026 sales of $498 million, up 4% from the prior-year quarter, and adjusted EBITDA of $121 million, up 2%. GAAP results were weaker: a net loss of $16 million compared with net income of $32 million a year earlier. The company also issued fiscal 2027 guidance of $1,905 million to $1,975 million in sales and $405 million to $435 million in adjusted EBITDA.

  • Q4 sales were $498 million, up 4%; sales volumes rose 3% and pricing rose 2%.
  • Net loss was $16 million, or ($0.35) per diluted share; adjusted diluted EPS was $1.12 versus $1.08 a year earlier.
  • Specialty Additives adjusted EBITDA fell 31% to $20 million, while Life Sciences adjusted EBITDA rose 16% to $64 million.
  • Fiscal 2027 guidance: sales of $1,905 million to $1,975 million and adjusted EBITDA of $405 million to $435 million; fiscal 2026 adjusted EBITDA was $385 million.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Jun 2026$497.00M+7.3% $0.35— $16.00M3.2%
Mar 2026$482.00M+0.6% $0.34-47.7% $16.00M3.3%
Dec 2025$386.00M-4.7% $-0.26— -$12.00M-3.1%
Sep 2025$477.00M-8.6% $0.62+77.1% $32.00M6.7%
Jun 2025$463.00M-14.9% $-16.21-13608.3% -$742.00M-160.3%
Mar 2025$479.00M-16.7% $0.65-72.8% $31.00M6.5%
Dec 2024$405.00M-14.4% $-3.50-786.3% -$165.00M-40.7%
Sep 2024$522.00M+1.0% $0.35— $16.00M3.1%

From Ashland Global's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2025$1.82B-13.7% $-18.23-642.6%-46.3%
FY2024$2.11B-3.6% $3.36+1.5%8.0%
FY2023$2.19B-8.4% $3.31-79.8%8.1%
FY2022$2.39B+13.3% $16.41+357.1%38.8%
FY2021$2.11B+4.7% $3.59—10.4%

Frequently asked questions

When is Ashland Global's next earnings date?

Ashland Global has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.

What did Ashland Global earn last quarter?

For the quarter ended Jun 2026, Ashland Global reported diluted EPS of $0.35 on revenue of $497.00M (+7.3%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.